{"publication_id":"d8f38608-04e9-4baf-a98a-b15cef29f955","method_note":"Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.","sources":[{"study":"Evaluation and comparison of efficacy and safety of tirzepatide, liraglutide and SGLT2i in patients with type 2 diabetes mellitus: a network meta-analysis","doi":"10.1186/s12902-024-01805-z","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"A randomized trial to investigate the efficacy and safety of once‐daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg","doi":"10.1111/jdi.13789","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Comprehensive analysis of real-world data on liraglutide treatment in patients with obesity: a multicenter national study","doi":"10.1186/s40001-025-02836-5","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"The safety and efficacy of liraglutide combined with metformin in clinical treatment of polycystic ovary syndrome patients: a meta-analysis","doi":"10.1186/s12905-025-03787-z","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Boosting weight loss after conversional Roux-en-Y Gastric Bypass with liraglutide and placebo use. A double-blind-randomized controlled trial","doi":"10.1097/JS9.0000000000000990","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Impact of liraglutide on albumin-to-creatinine ratio in type 2 diabetes mellitus: a meta-analysis","doi":"10.1186/s40001-025-02801-2","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trial","doi":"10.1038/s41591-025-04106-7","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis","doi":"10.3389/fphar.2025.1438318","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Is liraglutide safe and effective in the elderly obese patients?: A single center experience","doi":"10.1097/MD.0000000000042155","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials","doi":"10.3803/EnM.2020.934","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: the DELI transition trial","doi":"10.1007/s00125-025-06446-y","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Mental health changes after 4 months of weight loss treatment with the glucagon‐like peptide‐1 analogue liraglutide 3.0 mg","doi":"10.1111/dom.70393","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials","doi":"10.1007/s12325-026-03523-5","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effects of Liraglutide, Empagliflozin and Their Combination on Left Atrial Strain and Arterial Function","doi":"10.3390/medicina60030395","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"GLP-1 receptor agonists as an adjunct to bariatric surgery for weight loss and metabolic outcome improvement: a systematic review and meta-analysis","doi":"10.1007/s00423-025-03831-4","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Liraglutide and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery","doi":"10.1001/jamanetworkopen.2025.39848","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Efficacy of 12 months therapy with glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on weight regain after bariatric surgery: a real-world retrospective observational study","doi":"10.1186/s12902-025-01913-4","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Systemic and gut microbiome changes with metformin and liraglutide in youth-onset type 2 diabetes: the MIGHTY study","doi":"10.1080/19490976.2025.2558071","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Liraglutide and Recurrent Stroke by Baseline Insulin Resistance: A Post Hoc Analysis of the LAMP Trial","doi":"10.1161/STROKEAHA.125.056010","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Efficacy and safety of GLP-1 agonists in the treatment of T2DM: A systematic review and network meta-analysis","doi":"10.1038/s41598-025-09807-0","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: Results from a randomized clinical trial","doi":"10.1002/jcsm.13445","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"The influence of the glucagon‐like peptide‐1 receptor agonist, liraglutide, on dietary patterns and nutrient intakes in patients with obesity and prediabetes: A secondary analysis of a randomized controlled trial","doi":"10.1111/dom.16395","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetes","doi":"10.1186/s12933-025-02706-8","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial","doi":"10.1111/dom.16419","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Combination metformin and liraglutide in PCOS: clinical efficacy in women and preclinical insights from gut microbiome modulation in rats","doi":"10.3389/fendo.2025.1599879","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes","doi":"10.1001/jamainternmed.2025.5684","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Retinopathy risk factors in patients with type 2 diabetes on liraglutide","doi":"10.1097/MD.0000000000039026","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Liraglutide Treatment Improves Glycaemic Dysregulation, Body Composition, Cardiometabolic Variables and Uncontrolled Eating Behaviour in Adolescents with Severe Obesity","doi":"10.4274/jcrpe.galenos.2024.2023-10-10","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Comparison of Glucose Control by Added Liraglutide to Only Insulin Infusion in Diabetic Patient Undergoing Cardiac Surgery: A Preliminary Randomized-Controlled Trial","doi":"10.4103/aca.aca_214_20","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Once‐Weekly Semaglutide Versus Once‐Daily Liraglutide for Weight Loss in Adults: A Meta‐Analysis of Randomized Controlled Trials","doi":"10.1111/cts.70127","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"GLP ‐1 receptor agonists for treating obesity without diabetes: A systematic review and meta‐analysis of economic evaluations","doi":"10.1111/dom.70322","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta‐analysis","doi":"10.1111/dom.70028","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Effects of 3-month liraglutide treatment on oxidative stress and inflammation in type 2 diabetes patients with different urinary albumin-to-creatinine ratio categories","doi":"10.1097/MD.0000000000040438","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials","doi":"10.1111/dom.70298","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Efficacy and safety of GLP-1 receptor agonists for adolescents and children with obesity: a meta-analysis of randomized controlled trials","doi":"10.1186/s12902-026-02248-4","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Evaluating the effects of liraglutide, empagliflozin and linagliptin on mild cognitive impairment remission in patients with type 2 diabetes (LIGHT-MCI): study protocol for a multicentre, randomised controlled trial with an extension phase","doi":"10.1136/bmjopen-2024-095382","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials","doi":"10.1097/MD.0000000000037432","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Exploratory Analysis of Liraglutide Effects on Obstructive Sleep Apnea and Health‐Related Quality of Life in Individuals With Obesity and COPD: A Secondary Analysis of a Randomised Controlled Trial","doi":"10.1111/cob.70079","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Effect of weight loss and liraglutide on neutrophil gelatinase-associated lipocalin levels among individuals with overweight and knee osteoarthritis: Exploratory analyses of a randomized controlled trial","doi":"10.1016/j.ocarto.2024.100562","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Assessing the shadows: A meta-analysis of GLP-1 agonists and suicidal ideation","doi":"10.1097/MD.0000000000046173","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial","doi":"10.4093/dmj.2022.0342","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Preventive effect of liraglutide on postoperative delirium in elderly patients undergoing cardiac surgery: protocol for a single-centre, randomised, double-blind, placebo-controlled trial","doi":"10.1136/bmjopen-2025-110759","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder","doi":"10.1001/jamapsychiatry.2024.3599","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Long-term administration of liraglutide for weight management in pediatric patients under 18 years: evidence from 7 randomized controlled trials.","doi":"10.1038/s41390-025-04537-5","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching","doi":"10.1371/journal.pone.0341745","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Effect of liraglutide on depressive symptoms in overweight or obese patients with type 2 diabetes: protocol for a pilot randomized controlled trial","doi":"10.3389/fendo.2025.1629157","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Real-world cardiovascular effects of liraglutide: transportability analysis of the LEADER trial","doi":"10.1101/2025.05.12.25327466","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Suspected liraglutide (glucagon-like peptide-1 receptor agonist)-induced hyperthyroidism: A case report","doi":"10.51866/cr.886","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Efficacy and Safety of GLP- 1 Receptor Agonists in the Management of Weight Recurrence or Suboptimal Clinical Response after Undergoing Metabolic Bariatric Surgeries: A Meta-Analysis.","doi":"10.1007/s11695-025-07856-y","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Efficacy and safety of liraglutide in non-alcoholic fatty liver disease with or without type 2 diabetes: A systematic review and meta-analysis.","doi":"10.1111/dom.70301","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"GLP-1 receptor agonists in pediatric obesity and diabetes: a systematic review of efficacy, metabolic effects, and safety.","doi":"10.1016/j.diabres.2026.113400","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"New developments in GLP-1 agonist therapy for gestational diabetes: Systematic review on liraglutide, semaglutide, and exenatide from ClinicalTrials.gov","doi":"10.1097/MD.0000000000044917","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Incretin Analogues for Weight Reduction in Non-Diabetic Obese: A Review of Liraglutide, Semaglutide, and Tirzepatide Beyond Glycemic Control","doi":"10.5041/RMMJ.10565","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis.","doi":"10.1111/dom.70452","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Efficacy and Safety of Liraglutide in Adolescents Aged 12–15 Years with Obesity: a Prospective 24-week Observational","doi":"10.15690/pf.v22i2.2871","risk_of_bias":"not appraised in public sidecar","directness":"review-level"},{"study":"Use of flash glucose-sensing technology in patients with type 2 diabetes treated with liraglutide combined with CSII: a pilot study","doi":"10.1590/1414-431X20198652","risk_of_bias":"not appraised in public sidecar","directness":"primary"},{"study":"**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"},{"study":"**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen.","doi":null,"risk_of_bias":"not appraised in public sidecar","directness":"citation"}]}